Application 761044
- Type
- BLA
- Sponsor
- JANSSEN BIOTECH
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761044 | Stelara | ustekinumab | 351(a) | Rx | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | STELARA | USTEKINUMAB | INJECTABLE;INJECTION | 130MG/26ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stelara | USTEKINUMAB | Janssen Biotech, Inc. | c77a9664-e3bb-4023-b400-127aa53bca2b | 2026-09-08 | Warnings, Adverse reactions | BLA761044 57894-054 |
| ustekinumab | USTEKINUMAB | Janssen Biotech, Inc. | 23b486eb-f48d-47d4-815e-1313d4ebfbfa | 2026-08-31 | Warnings, Adverse reactions | BLA761044 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
| 57894-054 | Stelara | ustekinumab | Janssen Biotech, Inc. | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85701 | SUPPL | 2026-04-20 |
| 85702 | SUPPL | 2026-04-16 |
| 85694 | SUPPL | 2026-04-16 |
| 84062 | SUPPL | 2025-11-04 |
| 84050 | SUPPL | 2025-11-04 |
| 82730 | SUPPL | 2025-07-03 |
| 82692 | SUPPL | 2025-06-30 |
| 81871 | SUPPL | 2025-04-08 |
| 81810 | SUPPL | 2025-04-02 |
| 80240 | SUPPL | 2024-11-19 |
| 77901 | SUPPL | 2024-03-21 |
| 77874 | SUPPL | 2024-03-19 |
| 73702 | SUPPL | 2023-03-07 |
| 73698 | SUPPL | 2023-03-07 |
| 71677 | SUPPL | 2022-08-01 |
| 71676 | SUPPL | 2022-08-01 |
| 71673 | SUPPL | 2022-08-01 |
| 68781 | SUPPL | 2021-09-24 |
| 65593 | SUPPL | 2020-12-15 |
| 65581 | SUPPL | 2020-12-14 |
| 65580 | SUPPL | 2020-12-14 |
| 65467 | SUPPL | 2020-12-02 |
| 65459 | SUPPL | 2020-12-01 |
| 65458 | SUPPL | 2020-12-01 |
| 62547 | SUPPL | 2020-04-13 |
| 62546 | SUPPL | 2020-04-13 |
| 60840 | SUPPL | 2019-11-14 |
| 60839 | SUPPL | 2019-11-14 |
| 60808 | SUPPL | 2019-11-12 |
| 60598 | SUPPL | 2019-10-24 |
| 60608 | SUPPL | 2019-10-21 |
| 60607 | SUPPL | 2019-10-21 |
| 51048 | ORIG | 2018-01-12 |
| 45422 | ORIG | 2016-09-29 |
| 45480 | ORIG | 2016-09-26 |